United States General Surgical Devices Market

United States General Surgical Devices Market Overview:

The United States general surgical devices market size was valued at USD 4,319.20 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 7,346.91 Million by 2033, exhibiting a CAGR of 6.08% during 2025-2033.  The market is expanding due to an increased demand for advanced surgical technologies like minimally invasive and robotic assisted procedures. Innovations in surgical instruments and imaging technologies are improving precision and outcomes and enhancing efficiency in surgical settings, further augmenting the United States general surgical devices market share.

The market is primarily driven by the increasing demand for advanced surgical technologies and minimally invasive procedures that offer superior patient outcomes. Moreover, the considerable rise in technological innovations including enhanced imaging technologies and precision surgical tools is also acting as a significant growth-inducing factor for the market. In June 2025, Johnson & Johnson MedTech launched the ETHICON™ 4000 Stapler, featuring advanced 3D Stapling Technology to enhance surgical performance and reduce complications like leaks and bleeding. The stapler will be showcased at the American Society for Metabolic and Bariatric Surgery Annual Meeting and is also planned for exclusive use with the OTTAVA™ Robotic Surgical System in the future. In addition to this, the expanding number of hospitals implementing robotic surgical systems with numerous hospitals now utilizing these technologies is resulting in higher investment in premium, high-end surgical device variants.

The market is further driven by the implementation of favorable FDA approvals for innovative surgical devices and the continuous development of next-generation surgical technologies. Apart from this, easy accessibility of advanced surgical devices across major healthcare institutions and ambulatory surgical centers is propelling the market. In January 2025, JUNE MEDICAL and Aspen Surgical announced a strategic collaboration to expand the availability of the Galaxy II® Surgical Retractor in the U.S. market. The partnership will leverage Aspen Surgical’s distribution network to improve access to this award-winning, versatile surgical tool across various specialties. Some of the other factors contributing to the market include rapid digitalization in healthcare settings, the cultural shift towards precision medicine and personalized surgical approaches, and extensive research and development (R&D) activities by leading medical device manufacturers.

United States General Surgical Devices Market Trends:

Growth of Minimally Invasive Surgery

The growth of minimally invasive surgery is transforming the healthcare landscape as patients nowadays increasingly prefer procedures that offer quicker recovery, less pain and minimal scarring. According to an industry report, about 3 million minimally invasive procedures are performed by surgeons each year in the United States. This shift is fueled by the advancements in technology such as laparoscopic tools, endoscopic devices and robotic systems which allows surgeons to perform complex operations with smaller incisions. These innovations reduce the risk of infection and shorten the hospital stays, thus further contributing to their rising popularity. As per the United States general surgical devices market forecast, the demand for minimally invasive surgery has consequently driven the development of specialized surgical instruments and equipment, which will play a vital role in expanding the market for these advanced medical devices. For instance, in November 2023, Cleveland Clinic became the first medical center in the United States to successfully perform a minimally invasive gastric sleeve procedure using a newly FDA-approved surgery robot with magnetic technology. This advancement in robotic technology is enhancing minimally invasive surgery allowing for fewer incisions, reduced pain and quicker recovery for patients. Magnetic technology enables surgeons to manipulate tissue and organs gently as needed during surgery providing numerous benefits for both patients and surgeons.

Technological Advancements

Technological advancements in surgical devices are revolutionizing the field of surgery with innovations like robotic assisted systems, laparoscopic instruments and enhanced imaging technologies, and is one of the major United States general surgical devices market trends. Over 2,000 hospitals now use robotic surgical systems, making the U.S. a significant market. Robotic surgery systems offer unparalleled precision by providing surgeons with better control and flexibility which helps minimize errors and improve outcomes. Laparoscopic instruments are designed for minimally invasive procedures allows for smaller incisions, reduced recovery time and fewer complications. Enhanced imaging technologies such as 3D and real-time imaging enable more accurate diagnoses and precise surgical planning. These innovations collectively enhance patient safety optimize surgical performance and contribute to the growing popularity of advanced surgical technologies in healthcare settings. For instance, in February 2024, US FDA granted authorization to Virtual Incision Corporation for the MIRA Surgical System, the world's first miniaturized robotic-assisted surgery device. It is authorized for use in adults undergoing colectomy procedures. The compact and portable design of MIRA could potentially overcome challenges associated with existing mainframe surgical robots and expand access to robotic-assisted surgery. Virtual Incision plans to begin the commercialization in the United States and expand to additional sites over time with future indications including gynecology, general surgery, urology and other soft tissue and solid organ surgery.

United States General Surgical Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the United States general surgical devices market, along with forecasts at the regional and country/country and regional levels from 2025-2033. The market has been categorized based on product and application.

Analysis by Product:

• Handheld Devices
• Laparoscopic Devices
• Electro Surgical Devices
• Wound Closure Devices
• Trocars and Access Devices
• Others

Handheld surgical devices are used as essential tools across virtually all surgical procedures and medical specialties. These versatile instruments provide surgeons with direct tactile control and precision handling capabilities that remain irreplaceable despite technological advances in robotic and automated systems. The segment benefits from continuous innovation in materials science, ergonomic design, and manufacturing techniques that enhance durability, functionality, and user comfort while maintaining cost-effectiveness for healthcare institutions. Handheld devices offer immediate availability, require minimal setup time, and provide surgeons with familiar operational interfaces that facilitate seamless integration into existing surgical workflows.

Laparoscopic devices represent a rapidly expanding segment, and the United States general surgical devices market growth is driven by the fundamental shift toward minimally invasive surgical approaches that prioritize patient comfort and recovery optimization. These specialized instruments enable surgeons to perform complex abdominal and pelvic procedures through small incisions, significantly reducing tissue trauma, post-operative pain, and recovery duration compared to traditional open surgical methods. The segment benefits from continuous technological refinements including improved visualization systems, enhanced maneuverability features, and integrated energy delivery capabilities that expand procedural possibilities and surgical precision.

Electro surgical devices occupy a critical position in the United States general surgical devices market through their essential role in tissue cutting, coagulation, and surgical site management across diverse medical specialties. These sophisticated instruments utilize controlled electrical energy to achieve precise tissue effects while minimizing bleeding and optimizing surgical field visibility, contributing significantly to procedural safety and efficiency. The segment benefits from advanced technology integration including bipolar and monopolar energy systems, ultrasonic cutting capabilities, and intelligent tissue sensing features that automatically adjust energy delivery based on tissue characteristics.

Analysis by Application:

• Gynecology and Urology
• Cardiology
• Orthopedic
• Neurology
• Others

The gynecology and urology application segment encompasses a broad range of surgical procedures from routine diagnostic procedures to complex reconstructive surgeries, creating sustained demand for specialized surgical instruments and advanced technological solutions. The segment benefits from the widespread adoption of minimally invasive approaches in gynecological and urological procedures, driving demand for laparoscopic instruments, robotic surgical systems, and specialized imaging technologies. Patient preferences for procedures offering reduced recovery times, minimal scarring, and preserved functionality align perfectly with the capabilities of advanced surgical devices designed for these specialties.

The cardiology application segment represents a high-growth area within the United States general surgical devices market, driven by the increasing prevalence of cardiovascular diseases and the continuous evolution of cardiac surgical techniques. Cardiovascular procedures demand the highest levels of precision, reliability, and technological sophistication, creating substantial market opportunities for advanced surgical devices and specialized instrumentation. The segment benefits from rapid technological advancement in minimally invasive cardiac procedures, including transcatheter valve interventions, robotic cardiac surgery, and advanced imaging-guided procedures that require specialized surgical instruments.

The orthopedic application segment demonstrates significant growth potential within the United States general surgical devices market, fueled by an aging population, increased sports-related injuries, and advancing surgical techniques for musculoskeletal disorders. Orthopedic procedures require specialized instrumentation designed to handle the unique challenges of bone, joint, and soft tissue surgery, creating distinct market opportunities for innovative surgical devices. The segment benefits from technological advances including computer-assisted surgery systems, 3D printing applications for custom implants, and minimally invasive arthroscopic techniques that enhance surgical precision and patient outcomes.

Regional Analysis:

• Northeast
• Midwest
• South
• West

The Northeast region maintains its position as one of the leading market for general surgical devices in the United States through its concentration of world-renowned medical institutions, academic medical centers, and advanced healthcare infrastructure. This region hosts numerous prestigious hospitals and medical schools that serve as innovation hubs for surgical technology development and early adoption of cutting-edge medical devices. The demographic characteristics of the Northeast, including higher population density, aging demographics, and elevated healthcare utilization rates, create substantial demand for surgical procedures across multiple specialties and create a positive United States general surgical devices market outlook.

The Midwest region represents a significant and growing market for general surgical devices, characterized by robust healthcare systems, major medical centers, and strong manufacturing capabilities that support both consumption and production of surgical technologies. This region benefits from a diverse healthcare landscape including large metropolitan medical centers, regional hospitals, and extensive rural healthcare networks that collectively generate substantial demand for surgical instruments and devices. The Midwest's manufacturing heritage and engineering expertise contribute to medical device production capabilities, creating synergies between local manufacturing and healthcare delivery systems.

The South region demonstrates rapid expansion in the general surgical devices market, driven by population growth, healthcare system development, and increasing surgical procedure volumes across diverse medical specialties. This region experiences significant demographic shifts including population migration from other regions, creating increased healthcare demand and infrastructure development opportunities. The South's economic growth and business-friendly environment attract medical device companies and healthcare organizations, fostering market expansion and innovation.

The West region serves as a dynamic innovation hub for the United States general surgical devices market, leveraging its concentration of technology companies, medical device manufacturers, and progressive healthcare systems that pioneer advanced surgical technologies. This region's entrepreneurial culture and venture capital availability support startup companies and innovative medical device development initiatives that drive market evolution and technological advancement. The West Coast's demographic diversity and health-conscious population create unique market demands and opportunities for specialized surgical devices and minimally invasive procedures.

Competitive Landscape:

The competitive landscape of the United States general surgical devices market is characterized by strategic initiatives focused on technological innovation, clinical outcome improvement, and comprehensive portfolio expansion to address evolving healthcare needs. Key players are investing substantially in research and development activities to create next-generation surgical devices that incorporate artificial intelligence, robotic capabilities, and enhanced precision features. Companies are implementing strategic acquisition programs to expand their product portfolios and market reach, with recent examples including major transactions that strengthen capabilities in interventional cardiology, vascular procedures, and minimally invasive surgery. Digital health integration initiatives and smart surgical device development are becoming increasingly important as companies adapt to connected healthcare environments and data-driven surgical workflows.

The report provides a comprehensive analysis of the competitive landscape in the United States general surgical devices market with detailed profiles of all major companies, including:.

Latest News and Developments:

• April 2025: Johnson & Johnson MedTech announced the first clinical cases using its OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center. Led by Dr. Erik Wilson, the gastric bypass trial supports FDA De Novo submission for multiple general surgery procedures, marking a milestone in robotic-assisted minimally invasive surgery.
• April 2025: Intuitive received U.S. FDA clearance for its SP SureForm 45 stapler, the first stapler designed for single-port robotic surgery. Compatible with the da Vinci SP system, it supports thoracic, colorectal, and urologic procedures, offering SmartFire technology and enhanced surgeon control to improve efficiency and patient outcomes.
• April 2025: Medivis received FDA 510(k) clearance and launched its Spine Navigation platform in the U.S. The AR- and AI-powered system enhances spine surgery precision with holographic navigation, ergonomic AR hardware, and seamless integration, supporting neurosurgery and orthopedic procedures in hospitals and ambulatory surgical centers nationwide.
• February 2025: Teleflex announced a EUR 760 Million agreement to acquire BIOTRONIK’s Vascular Intervention business, expanding its interventional cardiology and peripheral vascular portfolio. The deal, expected to close by Q3 2025, adds drug-coated balloons, stents, and scaffold technologies, strengthening Teleflex’s global presence and growth prospects in cardiovascular interventions.
• August 2024: Olympus launched two new POWERSEAL Sealer/Divider 5mm devices, the Straight Jaw Double-action (SJDA) and Curved Jaw Single-action (CJSA). Expanding its advanced bipolar surgical energy portfolio, the devices offer strong vessel sealing, ergonomic comfort, and multifunctional capabilities for laparoscopic and open surgeries across multiple specialties, with regulatory clearance in major markets.
• August 2024: KARL STORZ completed its acquisition of Asensus Surgical for USD 0.35 per share, creating a U.S.-based surgical robotics hub. The merger strengthens KARL STORZ’s robotic and digital surgery portfolio, supporting development of the next-generation LUNA system and advancing Performance-Guided Surgery™ with enhanced visualization and surgical precision.

United States General Surgical Devices Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States general surgical devices market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the United States general surgical devices market.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States general surgical devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.